New Two-year Data Confirm Roche’s Vabysmo Improves Vision With Fewer Treatments for People With Neovascular Age-related Macular Degeneration
July 18, 2022
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced new two-year data from the TENAYA and LUCERNE studies that reinforce the long-term efficacy, safety and durability of Vabysmo® (faricimab) in neovascular or “wet” age-related macular degeneration (nAMD), a leading cause ...
chat_bubble0 Comment
visibility107 Views
Obesity Linked to Damaging Changes in Failing Hearts
June 9, 2022
Obesity is linked to changes in the structure and pumping action of the heart before it develops heart failure, according to research we’ve funded and presented at the British Cardiovascular Society conference in Manchester. In ...
chat_bubble0 Comment
visibility128 Views
Frozen Eggs More Efficient Option than IVF for Women Starting Families Later
May 27, 2022
The largest U.S. report of elective fertility preservation outcomes to date found that 70 percent of women who froze eggs when they were younger than 38 – and thawed at least 20 eggs at a ...
chat_bubble0 Comment
visibility112 Views
Popular Posts
